David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.34% |
| 2 | Healthcare | 11.75% |
| 3 | Consumer Discretionary | 9.24% |
| 4 | Financials | 7.7% |
| 5 | Communication Services | 6.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
Chefs' Warehouse
CHEF
$4.61B
| $2.95M | ﹤0.01% |
+292,881
| New | +$8.68M |
|
1802
New Oriental
EDU
$9.07B
| $2.95M | ﹤0.01% |
27,225
+21,789
| +401% | +$2.8M |
|
1803
CALL
Expedia Group
EXPE
$40.5B
| $2.94M | ﹤0.01% |
52,300
+21,600
| +70% | +$2.07M |
|
1804
Essex Property Trust
ESS
$18.7B
| $2.94M | ﹤0.01% |
13,362
-12,869
| -49% | -$3.7M |
|
1805
Interface
TILE
$2.23B
| $2.94M | ﹤0.01% |
389,074
-111,989
| -22% | -$1.56M |
|
1806
Valmont Industries
VMI
$9.22B
| $2.94M | ﹤0.01% |
27,753
-11,957
| -30% | -$1.55M |
|
1807
V2X
VVX
$2.43B
| $2.94M | ﹤0.01% |
71,004
-56,694
| -44% | -$2.89M |
|
1808
CALL
Expeditors International
EXPD
$24.8B
| $2.94M | ﹤0.01% |
+44,000
| New | +$3.14M |
|
1809
CALL
Teleflex
TFX
$5.91B
| $2.93M | ﹤0.01% |
10,000
| – | – |
|
|
GPMT
1810
Granite Point Mortgage Trust
GPMT
$51.1M
| $2.92M | ﹤0.01% |
576,749
+547,477
| +1,870% | +$8.29M |
|
1811
BILL Holdings
BILL
$4.75B
| $2.92M | ﹤0.01% |
+85,300
| New | +$4.04M |
|
1812
PUT
Acuity Brands
AYI
$10.2B
| $2.9M | ﹤0.01% |
33,900
| – | – |
|
1813
Renasant Corp
RNST
$3.75B
| $2.89M | ﹤0.01% |
132,510
+55,426
| +72% | +$1.65M |
|
1814
CALL
MarketAxess Holdings
MKTX
$5.73B
| $2.89M | ﹤0.01% |
8,700
-36,700
| -81% | -$12.8M |
|
1815
Rocket Pharmaceuticals
RCKT
$401M
| $2.89M | ﹤0.01% |
207,403
+188,976
| +1,026% | +$3.74M |
|
1816
PUT
MSCI
MSCI
$41B
| $2.89M | ﹤0.01% |
+10,000
| New | +$2.83M |
|
1817
Carlyle Secured Lending
CGBD
$785M
| $2.88M | ﹤0.01% |
552,692
-7,522
| -1% | -$89.1K |
|
1818
CALL
Ulta Beauty
ULTA
$23B
| $2.88M | ﹤0.01% |
16,400
-47,500
| -74% | -$11.8M |
|
|
FL
1819
DELISTED
Foot Locker
FL
| $2.88M | ﹤0.01% |
130,558
-110,587
| -46% | -$3.76M |
|
|
STMP
1820
CALL
DELISTED
Stamps.com, Inc.
STMP
| $2.88M | ﹤0.01% |
22,100
-48,800
| -69% | -$5.12M |
|
1821
Arlo Technologies
ARLO
$1.41B
| $2.87M | ﹤0.01% |
1,182,292
+358,111
| +43% | +$1.24M |
|
1822
PUT
AstraZeneca
AZN
$259B
| $2.87M | ﹤0.01% |
32,100
| – | – |
|
|
ITCI
1823
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.87M | ﹤0.01% |
186,447
-44,966
| -19% | -$977K |
|
1824
Blue Owl Capital
OBDC
$5.6B
| $2.86M | ﹤0.01% |
248,055
+206,676
| +499% | +$3.03M |
|
1825
Plexus
PLXS
$6.53B
| $2.85M | ﹤0.01% |
52,285
-4,680
| -8% | -$316K |
|
Similar funds
David Shaw's Q1 2020 Portfolio in Review
As of Q1 2020, David Shaw held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- David Shaw's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- David Shaw added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- David Shaw's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- David Shaw fully exited PG&E in Q1 2020, selling an estimated $79M.
- David Shaw's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- David Shaw opened 538 new positions and closed 626 in Q1 2020.
- David Shaw's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.